Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, By Product (Endotherapy, Endoscopes, Energy Devices, and Visualization), By Application, By Procedure, By Technology, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5212
|
Published Date
May 2026
|
Pages
345
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market size was valued at US$ 2,341.82 Million in 2025, expanding at a CAGR of 8.30% from 2026 to 2033.
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a minimally invasive medical procedure used to diagnose and treat conditions affecting the bile ducts and pancreas. In this technique, a thin, flexible endoscope is passed through the mouth into the small intestine, allowing physicians to access the bile and pancreatic ducts. Using real-time imaging guidance, doctors can identify blockages, strictures, or other abnormalities and often treat them during the same procedure. As a result, ERCP is primarily used for therapeutic rather than purely diagnostic purposes.
The demand for ERCP procedures is driven by the growing prevalence of gastrointestinal and hepatopancreatobiliary disorders worldwide. According to the World Health Organization, gastrointestinal diseases contribute significantly to the global burden of illness, increasing the need for advanced interventional treatments. The National Institute of Diabetes and Digestive and Kidney Diseases reports that gallstones affect more than 20 million people in the United States, many of whom may require duct-related procedures such as ERCP. In addition, the National Cancer Institute notes that tens of thousands of pancreatic cancer cases are diagnosed annually, with a considerable number involving bile duct complications that may require endoscopic intervention.
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market- Market Dynamics
Progress in Endoscopy Technology and Clinical Capabilities
Continuous advancements in imaging technologies and device design are significantly improving the safety, precision, and efficiency of Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures. Modern endoscopic systems now provide higher-resolution imaging, enhanced navigation within delicate biliary and pancreatic ducts, and improved control during therapeutic interventions. These innovations enable clinicians to identify abnormalities more accurately and perform procedures such as stone removal and stent placement with greater precision and reduced procedural risk.
Regulatory bodies such as the European Medicines Agency support the evaluation and approval of advanced endoscopic technologies, helping ensure that safer and more effective devices are introduced into healthcare systems. Similarly, Health Canada oversees the regulation of medical imaging and endoscopic equipment, encouraging innovation in minimally invasive diagnostic and therapeutic procedures. In Japan, the Ministry of Health, Labour and Welfare continues to promote the adoption of advanced clinical techniques and medical technologies, strengthening procedural capabilities across healthcare institutions. From an industry perspective, Stryker Corporation reports strong global performance supported by its diversified medical device portfolio, including imaging and endoscopic solutions. Likewise, HOYA Corporation, through its endoscopy division, continues to generate significant revenue driven by its advanced visualization and minimally invasive surgical technologies.
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market- Segmentation Analysis:
The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market is segmented on the basis of Product, Application, Procedure, Technology, End User, and Region.
Based on product classification, the market is segmented into four categories: endotherapy, endoscopes, energy devices, and visualization systems. Among these, endoscopes are expected to remain a key component due to their critical role in both diagnosis and treatment. These devices serve as the primary access tools, enabling physicians to navigate the bile and pancreatic ducts, visualize internal structures, and guide therapeutic interventions. As clinical demand continues to shift toward precise and minimally invasive procedures, the need for high-quality imaging and flexible scope design continues to support the widespread use of endoscopes across hospitals and specialty care centers. From a business perspective, Boston Scientific reports strong and sustained revenue contribution from its endoscopy portfolio, reflecting continued reliance on advanced endoscopic technologies in clinical practice. Similarly, Fujifilm Holdings Corporation has highlighted significant growth in its medical systems division, particularly in endoscopic imaging solutions used in gastrointestinal applications.
Based on procedure type, the market is divided into therapeutic and diagnostic categories. The therapeutic segment accounts for a substantial share of clinical usage, as modern medical practice has increasingly shifted from purely diagnostic applications toward active intervention. Today, ERCP procedures are more commonly used to treat conditions such as bile duct stone removal, obstruction relief, and stent placement rather than solely diagnosing disorders. This shift has been supported by advancements in non-invasive imaging techniques, which have reduced the need for ERCP in purely diagnostic roles. Industry participants such as Cook Medical report consistent global utilization of their ERCP accessory devices, particularly those used for stone extraction and stent placement, reflecting steady demand for therapeutic procedures. Likewise, Olympus Corporation continues to highlight strong demand for its therapeutic endoscopy platforms, which are widely used in interventional gastrointestinal procedures worldwide.
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market- Geographical Insights
Within global healthcare procedures, the ERCP market reflects how the prevalence of digestive disorders and the development of medical infrastructure progress in parallel. The Asia-Pacific region, in particular, stands out due to its large patient population and expanding clinical capabilities, which together are driving increased demand for endoscopic interventions.
Government-linked and clinical studies highlight a significant disease burden in the region. A study published by the National Center for Biotechnology Information reports chronic pancreatitis incidence ranging from 114 to 200 per 100,000 people in parts of India, indicating a substantial need for duct-related procedures such as ERCP. In China, national-level health data referenced in public health literature shows that pancreatitis cases increased from 380,018 in 1990 to 493,765 in 2019, reflecting a rising demand for hospital-based interventional procedures. Additionally, clinical insights supported by the National Institutes of Health identify gallstones as a leading cause of pancreatitis, a condition commonly observed in Asian populations and frequently managed through ERCP-based interventions.
Within this region, Japan presents a highly structured and advanced clinical environment for ERCP procedures, supported by comprehensive healthcare data systems and strong medical technology adoption. Evidence from the nationwide Diagnosis Procedure Combination database, referenced through the National Center for Biotechnology Information, indicates that more than 1,073,513 ERCP procedures were performed between 2016 and 2023, reflecting widespread clinical use across hospitals. Furthermore, a nationwide epidemiological survey supported by the Ministry of Health, Labour and Welfare estimated approximately 78,450 cases of acute pancreatitis in 2016, highlighting a significant patient base requiring pancreatic and biliary interventions. From an industry perspective, Olympus Corporation continues to support this clinical ecosystem through the development and supply of advanced endoscopy systems widely used in ERCP procedures across healthcare facilities.
U.S. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market- Country Insights
In the United States, the use of Endoscopic Retrograde Cholangiopancreatography (ERCP) is supported by a well-established clinical ecosystem driven by strong public health infrastructure and continuous medical innovation. The procedure is routinely performed in advanced hospital settings by specialized clinicians for the diagnosis and treatment of disorders affecting the bile ducts and pancreas.
According to the National Institute of Diabetes and Digestive and Kidney Diseases, gallstones affect nearly 25 million people in the country, many of whom may require bile duct interventions such as ERCP. In addition, the Centers for Disease Control and Prevention reports more than 300,000 hospital admissions annually related to gallstone disease, indicating a steady and ongoing demand for related procedures. The National Cancer Institute also notes approximately 64,000 new cases of pancreatic cancer each year, where ERCP may play a supportive role in diagnosis and clinical management.
From an industry perspective, Boston Scientific generates approximately USD 14 billion in annual revenue, supported in part by its endoscopy portfolio, which serves a wide range of gastrointestinal procedures. Similarly, Cook Medical maintains a comprehensive ERCP accessory portfolio with global distribution, ensuring consistent availability of tools required for therapeutic endoscopic procedures.
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market- Competitive Landscape:
Driven by the rising demand for minimally invasive gastrointestinal procedures, the ERCP device market is shaped by a mix of global medical device manufacturers and specialized technology providers. Companies such as Fujifilm Holdings Corporation, Medtronic, Cook Medical, Boston Scientific, and Karl Storz play a key role through continuous product innovation, physician training initiatives, and strategic distribution partnerships.
These companies focus on improving visualization technologies, enhancing device precision, and strengthening procedural safety, while maintaining robust supply networks across hospitals and specialty care centers. For example, Medtronic has expanded its gastrointestinal portfolio with advanced endoscopic solutions designed to support complex biliary interventions. Similarly, Fujifilm Holdings Corporation has strengthened its endoscopy offerings with enhanced imaging technologies aimed at improving diagnostic clarity and procedural accuracy. Overall, these developments reflect a gradual shift toward safer, more efficient, and more precise ERCP practices in modern healthcare settings.
Recent Developments
- In March 2025, Olympus Corporation introduced an updated duodenoscope featuring enhanced imaging capabilities and disposable components to support improved infection control during ERCP procedures. This development aligns with evolving regulatory expectations regarding endoscope safety and helps reduce infection risks while improving procedural reliability.
- In January 2025, Boston Scientific expanded its endoscopy portfolio with new ERCP-compatible stent systems designed to improve the management of biliary strictures. These systems enable more precise stent placement and support better clinical outcomes in patients undergoing ERCP-based interventions.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Boston Scientific Corporation
- Olympus Corporation
- Cook Medical
- Medtronic plc
- CONMED Corporation
- Fujifilm Holdings Corporation
- Stryker Corporation
- PENTAX Medical (HOYA Corporation)
- Smith & Nephew plc
- KARL STORZ SE & Co. KG
- B. Braun Melsungen AG
- STERIS plc
- Richard Wolf GmbH
- Cantel Medical (STERIS company)
- Medi-Globe Corporation
- Becton, Dickinson and Company (BD)
- Ambu A/S
- HOBBS Medical, Inc.
- Zhejiang Chuangxiang Medical Technology Co., Ltd.
- Medorah Meditek Pvt. Ltd.
- Karl Storz Endoscopy Systems (KARL STORZ group units)
- Ethicon (Johnson & Johnson MedTech)
- Others
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Endotherapy
- Endoscopes
- Energy Devices
- Visualization
- Others
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Biliary Sphincterotomy
- Biliary Stenting
- Biliary Dilatation
- Pancreatitis Sphincterotomy
- Pancreatic Duct Stenting
- Pancreatic Duct Dilatation
- Others
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET, BY PROCEDURE- MARKET ANALYSIS, 2020 - 2033
- Therapeutic
- Diagnostic
- Others
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Conventional Endoscopy
- Endoscopic Ultrasound
- Single-Operator Endoscopy
- Others
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Ambulatory Surgery Centers
- Hospitals And Clinics
- Others
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Snippet by Product
2.1.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Snippet by Application
2.1.3. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Snippet by Procedure
2.1.4. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Snippet by Technology
2.1.5. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Snippet by End User
2.1.6. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Snippet by Country
2.1.7. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Snippet by Region
2.2. Competitive Insights
3. Endoscopic Retrograde Cholangiopancreatography (ERCP) Key Market Trends
3.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Opportunities
3.4. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Future Trends
4. Endoscopic Retrograde Cholangiopancreatography (ERCP) Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Landscape
6.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
7.1.2. Endotherapy
7.1.3. Endoscopes
7.1.4. Energy Devices
7.1.5. Visualization
7.1.6. Others
8. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Biliary Sphincterotomy
8.1.3. Biliary Stenting
8.1.4. Biliary Dilatation
8.1.5. Pancreatitis Sphincterotomy
8.1.6. Pancreatic Duct Stenting
8.1.7. Pancreatic Duct Dilatation
8.1.8. Others
9. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market – By Procedure
9.1. Overview
9.1.1. Segment Share Analysis, By Procedure, 2025 & 2033 (%)
9.1.2. Therapeutic
9.1.3. Diagnostic
9.1.4. Others
10. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market – By Technology
10.1. Overview
10.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
10.1.2. Conventional Endoscopy
10.1.3. Endoscopic Ultrasound
10.1.4. Single-Operator Endoscopy
10.1.5. Others
11. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
11.1.2. Ambulatory Surgery Centers
11.1.3. Hospitals And Clinics
11.1.4. Others
12. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.18. Denmark
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Denmark Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.18.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.18.5. Denmark Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.3.18.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.19. Rest of Europe
12.3.19.1. Overview
12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.19.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.19.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.19.5. Rest of the Europe Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.3.19.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.17. Taiwan
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.17.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.17.5. Taiwan Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.4.17.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.18. Vietnam
12.4.18.1. Overview
12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.18.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.18.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.18.5. Vietnam Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.4.18.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.19. Rest of APAC
12.4.19.1. Overview
12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.19.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.19.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.19.5. Rest of APAC Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.4.19.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.15. Iran
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.15.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.15.5. Iran Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.6.15.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.16. Qatar
12.6.16.1. Overview
12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.16.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.16.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.16.5. Qatar Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.6.16.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.17. Rest of MEA
12.6.17.1. Overview
12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.17.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.17.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.17.5. Rest of MEA Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
12.6.17.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Endoscopic Retrograde Cholangiopancreatography (ERCP) Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Boston Scientific Corporation
13.2.2. Olympus Corporation
13.2.3. Cook Medical
13.2.4. Medtronic plc
13.2.5. CONMED Corporation
13.2.6. Fujifilm Holdings Corporation
13.2.7. Stryker Corporation
13.2.8. PENTAX Medical (HOYA Corporation)
13.2.9. Smith & Nephew plc
13.2.10. KARL STORZ SE & Co. KG
13.2.11. B. Braun Melsungen AG
13.2.12. STERIS plc
13.2.13. Richard Wolf GmbH
13.2.14. Cantel Medical (STERIS company)
13.2.15. Medi-Globe Corporation
13.2.16. Becton, Dickinson and Company (BD)
13.2.17. Ambu A/S
13.2.18. HOBBS Medical, Inc.
13.2.19. Zhejiang Chuangxiang Medical Technology Co., Ltd.
13.2.20. Medorah Meditek Pvt. Ltd.
13.2.21. Karl Storz Endoscopy Systems (KARL STORZ group units)
13.2.22. Ethicon (Johnson & Johnson MedTech)
13.2.23. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Boston Scientific Corporation
- Olympus Corporation
- Cook Medical
- Medtronic plc
- CONMED Corporation
- Fujifilm Holdings Corporation
- Stryker Corporation
- PENTAX Medical (HOYA Corporation)
- Smith & Nephew plc
- KARL STORZ SE & Co. KG
- B. Braun Melsungen AG
- STERIS plc
- Richard Wolf GmbH
- Cantel Medical (STERIS company)
- Medi-Globe Corporation
- Becton, Dickinson and Company (BD)
- Ambu A/S
- HOBBS Medical, Inc.
- Zhejiang Chuangxiang Medical Technology Co., Ltd.
- Medorah Meditek Pvt. Ltd.
- Karl Storz Endoscopy Systems (KARL STORZ group units)
- Ethicon (Johnson & Johnson MedTech)
- Others
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Endotherapy
- Endoscopes
- Energy Devices
- Visualization
- Others
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Biliary Sphincterotomy
- Biliary Stenting
- Biliary Dilatation
- Pancreatitis Sphincterotomy
- Pancreatic Duct Stenting
- Pancreatic Duct Dilatation
- Others
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET, BY PROCEDURE- MARKET ANALYSIS, 2020 - 2033
- Therapeutic
- Diagnostic
- Others
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Conventional Endoscopy
- Endoscopic Ultrasound
- Single-Operator Endoscopy
- Others
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Ambulatory Surgery Centers
- Hospitals And Clinics
- Others
GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
